Literature DB >> 7149872

Systemic effects of eye drops.

A G Adler, G E McElwain, G J Merli, J H Martin.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7149872     DOI： 10.1001/archinte.142.13.2293

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

Review 1.  Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Authors:  Nevio Cimolai
Journal:  Clin Med Res       Date:  2019-08-28

Review 2.  Oxidation phenotype and the metabolism and action of beta-blockers.

Authors:  M S Lennard
Journal:  Klin Wochenschr       Date:  1985-04-01

3.  Ocular phenylephrine 2.5% continues to be dangerous.

Authors:  Nauman Ahmed; Waleed Riad; Abdullah Altorpaq; Abdul Zahoor
Journal:  BMJ Case Rep       Date:  2009-03-02

Review 4.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

5.  Mental status changes induced by eye drops in dementia of the Alzheimer type.

Authors:  P F Reyes; B A Dwyer; R J Schwartzman; T Sacchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.